论文部分内容阅读
目的观察普米克气雾剂吸入治疗婴幼儿哮喘的疗效。方法选择3个月内哮喘发作2次以上的婴幼儿共60例为观察对象,采用面罩式双阀型储雾器吸入普米克气雾剂,剂量初始200~400ug/d,病情稳定后渐降至100~200μg/d。观察3个月后临床症状及体征改变情况(计分法)及3个月内哮喘发作、副作用等。结果治疗后患儿临床症状及体征明显好转,临床症状、体征评分由治疗前的(5.4±1.02)分,降至(0.27±0.57)分,经统计学处理,差异十分显著(P<0.01);60例患儿除8例不依从医嘱10人次哮喘急性发作外,余未出现复发;未发现鹅口疮、声音嘶哑等副作用。结论普米克小剂量吸入,能有效地控制婴幼儿哮喘,具有安全、有效、方法简单等优点。
Objective To observe the curative effect of Pulmicort inhalation on infant asthma. Methods A total of 60 infants and young children with asthma attack more than 2 times in 3 months were selected as the observation objects. Pulmicort aerosol was inhaled with a mask-type double-valve vaporizer. The initial dosage was 200-400ug / d, To 100 ~ 200 μg / d. Observed after 3 months of clinical symptoms and signs of change (score method) and 3 months of asthma attacks, side effects. Results After treatment, the clinical symptoms and signs of children improved significantly. The score of clinical symptoms and signs decreased from (5.4 ± 1.02) to (0.27 ± 0.57) before treatment, and the difference was statistically significant (P <0.01) ; 60 cases of children in addition to 8 cases do not comply with the order of 10 people with acute asthma attacks, I did not recur; no side effects such as thrush, hoarseness were found. Conclusions Pulmicort small dose inhalation, can effectively control infant asthma, safe, effective, simple method and so on.